Shares of Precigen (NASDAQ:PGEN) added ~34% in the premarket on Friday after the U.S. Food and Drug Administration (FDA) ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

According to the statement, the group’s operations target only “the Pakistan Army, Frontier Corps, intelligence networks, so-called death squads, and their collaborator gangs” inside Balochistan.

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

Leadership and talent actions -- Lisa Wolf confirmed as CFO; key hires from Statera joined for regulatory, clinical, and ...

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided recent business highlights.

Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 ...

GAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. R&D expenses (GAAP) rose 19% to $23.4 million in Q2 2025 compared to Q2 2024, primarily due to higher ...

Explore Inovio Pharmaceuticals' Q2 2025 earnings call highlights, including progress on INO-3107, regulatory milestones, financial updates, and ...